Avantor Inc.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Avantor meets Q4 expectations, eyes bioproduction growth in 2023

Avantor delivered solid financial performance in Q4 and exceeded full-year revenue targets.
The company's focus on operational enhancements and global expansion supports future growth.
Challenges in the first quarter are being addressed with a focus on productivity and cost management.
Opportunities in bioproduction growth, M&A, and working capital improvements position Avantor for success.

Avantor Inc. reports Q1 revenue decline, eyes semiconductor market rebound

Avantor Inc. navigated challenges in Q1 with revenue declines due to destocking and semiconductor downturn, while showcasing strengths in innovation and acquisitions performance.
Management's confidence in the long-term strategy and focus on margin improvement present opportunities for growth and recovery in 2023, despite ongoing market challenges.
Strategic approaches to address destocking headwinds and market dynamics in different regions position Avantor Inc. for potential growth and resilience in the coming quarters.
Overall, Avantor Inc. faces challenges from market uncertainties but remains poised to leverage opportunities for growth, innovation, and margin improvement in the evolving landscape.

Avantor Inc. reports Q2 revenue decline, focuses on cost controls

Avantor Inc. faced revenue and EPS cuts in Q2 2023, driven by market challenges in biopharma and semiconductors. The company focused on cost savings, debt reduction, and operational efficiency. Challenges included limited visibility in research space and mid- to high single-digit organic decline in bioproduction.

Avantor Inc. reports Q3 revenue contraction, eyes growth opportunities

Avantor Inc. navigated challenges in Q3 2023 with a focus on growth and operational improvements.
Management's cautious yet optimistic stance reflects a strategic approach to customer sentiment and inventory health.
Outlook for 2024 remains uncertain, but the company is positioned to capitalize on opportunities in key markets.
Analyst questions addressed various topics, highlighting the company's proactive engagement with stakeholders.

Avantor Inc. exceeds Q4 expectations, eyes cost savings and margin growth

Avantor Inc. delivered solid Q4 results, focusing on executing business model transformation and driving growth strategy. Despite challenges in market conditions and revenue decline, the company is optimistic about cost-saving initiatives and margin improvement opportunities.

Avantor Inc. reports Q1 revenue decline but optimistic on growth

Avantor Inc. delivered mixed performance in Q1 2024 with revenue decline but strong margin and debt reduction. Despite challenges in certain segments and regions, the company remains optimistic about growth opportunities in key markets and cost-saving initiatives.

Avantor reports solid Q2 earnings, eyes growth in Bioprocessing segment

Avantor Inc.'s Q2 2024 performance showcased solid revenue, margin improvement, and strong segmental growth. While facing challenges in organic revenue decline and segmental performance, the company's focus on cost transformation and positive outlook signal resilience and potential for growth. Avantor's opportunities lie in leveraging Bioprocessing momentum and cost-saving initiatives for sustained performance enhancement.

Avantor Inc. reports solid Q3 performance and accelerates growth strategies

Avantor's Q3 performance reflects resilience and strategic focus amidst market challenges, with notable achievements in revenue, margin, and divestiture.
The company's strengths in innovation, operational excellence, and market positioning position it well for long-term growth and profitability.
While facing challenges in certain segments and cost transformation, Avantor's opportunities in renewable energy, cash flow, and market growth are promising.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the following geographical segments: the Americas, Europe, and AMEA. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Avantor's (AVTR) CEO Michael Stubblefield on Q2 2021 Results - Earnings Call Transcript

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 16.67% and 7.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Q2 Earnings and Revenues Top Estimates

RADNOR, Pa., July 29, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today reported financial results for the quarter ended June 30, 2021.

Avantor® Reports Second Quarter 2021 Results

RADNOR, Pa., July 22, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today published its first sustainability report.

Avantor® Publishes Inaugural Sustainability Report; Drives Positive Impact through Science for Goodness Platform

RADNOR, Pa., July 16, 2021  /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it has changed the date of its previously announced earnings release and conference call.

Avantor® Announces Date Change for Second Quarter 2021 Earnings Release and Conference Call

Avantor continues its climb on the charts, posting a 100% single-year return. The company offers a unique value proposition for low-gamma seekers or those seeking low-volatility inclusions into portfolios.

Avantor: Diversified Portfolio Mix Continues To Deliver Upside

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Avantor, Inc. (AVTR) Soars to 52-Week High, Time to Cash Out?

RADNOR, Pa., July 6, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its financial results for the second quarter 2021 after the market closes on Wednesday, July 28, 2021, and will hold a conference call on the same day to discuss the results at 5:00 p.m.

Avantor® to Report Second Quarter 2021 Earnings and Host Earnings Call on Wednesday, July 28, 2021

Does Avantor, Inc. (AVTR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why Momentum Investors Will Love Avantor, Inc. (AVTR)

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Avantor (AVTR).

Is Avantor (AVTR) a Great Growth Stock?

Avantor, Inc. (AVTR) Hits 52-Week High, Can the Run Continue?

RADNOR, Pa., June 10, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today it has completed its previously announced acquisition of Ritter GmbH and its affiliates.

Avantor® Completes Acquisition of Ritter GmbH and its Affiliates

RADNOR, Pa. and SHANGHAI, June 1, 2021 /PRNewswire/ --  Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Avantor® Acquires RIM Bio; Expands Bioproduction Footprint into China

RADNOR, Pa., May 19, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021.

Avantor® to Present at Goldman Sachs 42nd Annual Global Healthcare Conference

Time to Focus on Avantor (AVTR) for Strong Earnings Growth Potential

Boise Cascade

Herc Hlds

Total

Top Ranked Growth Stocks to Buy for May 3rd

Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q1 2021 Results - Earnings Call Transcript

RADNOR, Pa., April 28, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the first quarter ended March 31, 2021.

Avantor® Reports First Quarter 2021 Results

Avantor, Inc. continues to present a compelling investment case, with industry drivers and portfolio insulators tied into the debate.

Avantor, Inc.: Portfolio Mix Hedges Top Line, Offers Unique Value Proposition

Apollo Medical Hlds

COMPASS Pathways

GoodRx Holdings

5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges

RADNOR, Pa., April 27, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.

Avantor® to Present at BofA Securities 2021 Virtual Health Care Conference

RADNOR, Pa., April 26, 2021 /PRNewswire/ -- Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.

Avantor® to Boost Global Production of Single­-Use Technologies and Address Growing Biopharma Demand

In the news release, Avantor® Declares Dividend on Mandatory Convertible Preferred Stock, issued 21-Apr-2021 by Avantor and Financial News over PR Newswire, we are advised by the company that the date at the end of the first paragraph, last sentence, should read "May 1, 2021" rather than "April 1, 2021" as originally issued inadvertently. The complete, corrected release follows: Avantor® Declares Dividend on Mandatory Convertible Preferred Stock RADNOR, Pa.

/C O R R E C T I O N -- Avantor and Financial News/

Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avantor, Inc. (AVTR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Avantor Performance Materials, Inc. (NYSE: AVTR) is buying Ritter GmbH and its affiliates in an all-cash transaction with an upfront equity purchase price of approximately €890 million. These are the details.

News for Avantor Inc. Stock (AVTR)